作者：
Peter,McColgan [1]
;
Alpa,Thobhani [1]
;
Lauren,Boak [2]
;
Scott A,Schobel [2]
;
Alessia,Nicotra [1]
;
Giuseppe,Palermo [2]
;
Dylan,Trundell [1]
;
Julian,Zhou [3]
;
Valerie,Schlegel [2]
;
Patricia,Sanwald Ducray [2]
;
David J,Hawellek [2]
;
Jonas,Dorn [2]
;
Cedric,Simillion [2]
;
Michael,Lindemann [2]
;
Vicki,Wheelock [4]
;
Alexandra,Durr [5]
;
Karen E,Anderson [6]
;
Jeffrey D,Long [7]
;
Edward J,Wild [8]
;
G Bernhard,Landwehrmeyer [9]
;
Blair R,Leavitt [10]
;
Sarah J,Tabrizi [11]
;
Rachelle,Doody [2]
;
GENERATION HD1 Investigators
作者单位：
Roche Products, Welwyn Garden City, United Kingdom.
[1]
F. Hoffmann-La Roche, Basel, Switzerland.
[2]
Roche Pharma Product Development China, Shanghai, China.
[3]
University of California, Davis, Davis, CA.
[4]
Paris Brain Institute, Paris, France.
[5]
Georgetown University School of Medicine, Washington, DC.
[6]
University of Iowa Health Care, Iowa City, IA.
[7]
University College London Queen Square Institute of Neurology, London, United Kingdom.
[8]
Ulm University, Ulm, Germany.
[9]
University of British Columbia, Vancouver, BC, Canada.
[10]
University College London Queen Square Institute of Neurology, London, United Kingdom s.tabrizi@ucl.ac.uk.
[11]
DOI
10.1056/NEJMc2300400
PMID
38055260
发布时间
2024-03-20
换一批
换一批
